Simple, sensitive and rapid determination of linifanib (ABT-869), a novel tyrosine kinase inhibitor in rat plasma by UHPLC-MS/MS

Chemistry Central Journal ◽

10.1186/1752-153x-8-13 ◽

2014 ◽

Vol 8 (1) ◽

Author(s):

Muzaffar Iqbal ◽

Essam Ezzeldin ◽

Tanveer A Wani ◽

Nasr Y Khalil

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Rapid Determination ◽

Download Full-text

Determination of tyrosine kinase inhibitor afatinib in rat plasma using LC–MS/MS and its application to in vivo pharmacokinetic studies of afatinib liposomes

Journal of Pharmaceutical and Biomedical Analysis ◽

10.1016/j.jpba.2018.10.043 ◽

2019 ◽

Vol 164 ◽

pp. 181-186 ◽

Author(s):

Xiaoyan Lu ◽

Sha Liu ◽

Xiucheng Yang ◽

Meishan Han ◽

Kaoxiang Sun

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Pharmacokinetic Studies

Download Full-text

Enhanced spectrofluorimetric determination of the multitargeted tyrosine kinase inhibitor, crizotinib, in human plasma via micelle-mediated approach

Tropical Journal of Pharmaceutical Research ◽

10.4314/tjpr.v15i10.20 ◽

2016 ◽

Vol 15 (10) ◽

pp. 2209 ◽

Author(s):

Hany W. Darwish ◽

Ahmed H. Bakheit ◽

Ibrahim A. Darwish

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Human Plasma ◽

Kinase Inhibitor ◽

Spectrofluorimetric Determination ◽

Multitargeted Tyrosine Kinase Inhibitor

Download Full-text

Determination of the maximum tolerated dose (MTD) of MGCD265, an oral Met/VEGFR multitargeted receptor tyrosine kinase inhibitor, in combination with docetaxel.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.3032 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 3032-3032

Author(s):

D. W. Rasco ◽

A. Patnaik ◽

R. K. Amaravadi ◽

K. P. Papadopoulos ◽

N. B. Haas ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Maximum Tolerated Dose ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

Development and validation of RP-HPLC method for the determination of Pazopanib Hydrochloride (A tyrosine kinase inhibitor) in pharmaceutical dosage form

Research Journal of Pharmacy and Technology ◽

10.5958/0974-360x.2021.00273.0 ◽

2021 ◽

Vol 14 (3) ◽

pp. 1549-1554

Author(s):

P. Ravi Sankar ◽

K. Saisneha Latha ◽

A. Bhavani Sailu ◽

SK. Taheera ◽

B. Madhuri

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Dosage Form ◽

Kinase Inhibitor ◽

Hplc Method ◽

Pharmaceutical Dosage Form ◽

Rp Hplc ◽

Development And Validation

Download Full-text

Total Synthesis and Structural Determination of XR774, a Tyrosine Kinase Inhibitor

The Journal of Organic Chemistry ◽

10.1021/acs.joc.7b02997 ◽

2018 ◽

Vol 83 (13) ◽

pp. 7010-7018 ◽

Author(s):

Kuniaki Tatsuta ◽

Daisuke Sekine ◽

Shinichi Hayama ◽

Yasuhiro Kataoka ◽

Shinya Hayashi ◽

...

Keyword(s):

Tyrosine Kinase ◽

Total Synthesis ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Structural Determination

Download Full-text

Determination of the maximum tolerated dose (MTD) of the CNS penetrant tyrosine kinase inhibitor (TKI) tesevatinib administered in combination with trastuzumab in HER2+ patients with metastatic breast cancer (BC).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.514 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 514-514 ◽

Author(s):

Nancy U. Lin ◽

Rachel A. Freedman ◽

Kathy Miller ◽

Komal L. Jhaveri ◽

David A. Eiznhamer ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Metastatic Breast ◽

Maximum Tolerated Dose

Download Full-text

Both Antiangiogenesis- and Angiogenesis-Independent Effects Are Responsible for Hepatocellular Carcinoma Growth Arrest by Tyrosine kinase Inhibitor PTK787/ZK222584

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70211-2 ◽

2006 ◽

Vol 2006 ◽

pp. 309-310

Author(s):

P.J. Loehrer

Keyword(s):

Hepatocellular Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Arrest ◽

Independent Effects

Download Full-text

Dual-agent molecular targeting of growth factor receptors in hepatocellular cancer: Combining anti-EGFR antibody with an EGFR tyrosine kinase inhibitor

Zeitschrift für Gastroenterologie ◽

10.1055/s-2005-920152 ◽

2005 ◽

Vol 43 (05) ◽

Author(s):

A Hüther ◽

M Höpfner ◽

D Schuppan ◽

H Scherübl

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Hepatocellular Cancer ◽

Growth Factor Receptors ◽

Molecular Targeting ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Download Full-text

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

10.32388/jfobd7 ◽

2020 ◽

Author(s):

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Epidermal Growth

Download Full-text

A Case of Metastatic Renal Cell Carcinoma to the Maxillary Sinus Treated with Tyrosine Kinase Inhibitor

Korean Journal of Otorhinolaryngology - Head and Neck Surgery ◽

10.3342/kjorl-hns.2012.55.11.717 ◽

2012 ◽

Vol 55 (11) ◽

pp. 717 ◽

Author(s):

Young Hyo Kim ◽

Jae Eun Kim ◽

Sungmin Park ◽

Tae Young Jang

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Maxillary Sinus ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor

Download Full-text